Meanwhile, studies have also reported that IL-33 may play an undetermined role in obesity and its cardiovascular or diabetic complications since the specific role of IL-33 in the pathogenesis and development of several metabolic diseases seems to be inconsistent [9, 14–17]. This evidence concerns the gene IL33 and obesity due to melanocortin 4 receptor deficiency.